PHK
APLT

Point72 Hong Kong’s Applied Therapeutics APLT Stock Holding History

Point72 Hong Kong’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-550
Closed -$1K – 1895
2022
Q1 		$1K Hold
550
– – ﹤0.01% 1747
2021
Q4 		$5K Sell
550
-55
-9% -$722 ﹤0.01% 1724
2021
Q3 		$10K Buy
+605
New +$10.4K ﹤0.01% 1792
2021
Q2 		– Sell
-424
Closed -$8K – 1897
2021
Q1 		$8K Sell
424
-7
-2% -$151 ﹤0.01% 1605
2020
Q4 		$9K Buy
431
+259
+151% +$5.39K ﹤0.01% 1547
2020
Q3 		$4K Sell
172
-1,189
-87% -$30.9K ﹤0.01% 1070
2020
Q2 		$49K Buy
1,361
+1,055
+345% +$44.2K 0.01% 741
2020
Q1 		$10K Buy
+306
New +$12.4K ﹤0.01% 675

Other funds holding APLT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Point72 Hong Kong's APLT Position: Q2 2022 in Review

Point72 Hong Kong sold out of Applied Therapeutics (APLT) in Q2 2022, closing a stake of 550 shares — an estimated $1K sold.

Point72 Hong Kong first reported a position in APLT in Q1 2020 and held it in 8 quarters. The position peaked at $49K in Q2 2020. 53 funds tracked by Wall St. Rank hold APLT as of Q2 2022.

  • Point72 Hong Kong reported no remaining Applied Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 550 Applied Therapeutics shares in Q2 2022, an estimated $1K.
  • Point72 Hong Kong first reported a position in Applied Therapeutics in Q1 2020 and held it in 8 quarters.
  • Point72 Hong Kong's Applied Therapeutics position peaked at $49K in Q2 2020.
  • 53 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.